| |
| |
|
| Insider
Information: |
Siegall Clay B |
| Relationship: |
|
| City: |
Bothell |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
1,088,246 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$158,715,111 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,088,246 |
|
|
| Total
Value |
$158,715,111 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
7
|
|
Stock
price went up :
|
3
|
4
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
3.0
|
1.3
|
| Percentage
Gain/Loss : |
 43.1%
|
19.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Seagen Inc |
SGEN |
President & CEO, Direc... |
2022-05-12 |
666,060 |
2016-09-10 |
0 |
Premium* |
|
|
Alder Biopharmaceuticals Inc |
ALDR |
Director |
2019-10-22 |
0 |
2014-05-13 |
0 |
Premium* |
|
|
Ultragenyx Pharmaceutical Inc |
RARE |
Director |
2020-08-10 |
2,550 |
2016-06-09 |
0 |
Premium* |
|
|
Immunome Inc. |
IMNM |
|
2024-05-21 |
419,636 |
2023-10-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
376 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 16
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IMNM |
Immunome Inc. |
President and CEOOfficer |
• • – |
2023-10-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
150,432 |
|
% |
|
| SGEN |
Seagen Inc |
President and CEO |
• • – |
2005-07-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
1,286,500 |
|
- |
|
| SGEN |
Seagen Inc |
President and CEO |
• • – |
2011-01-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,833 |
945,667 |
0 |
- |
|
| SGEN |
Seagen Inc |
President and CEO |
• • – |
2011-08-19 |
4 |
A |
$0.00 |
$0 |
D/D |
18,137 |
968,804 |
0 |
- |
|
| SGEN |
Seagen Inc |
President and CEO |
• • – |
2011-08-24 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
1,028,804 |
0 |
- |
|
| SGEN |
Seagen Inc |
President & CEO |
• • – |
2012-03-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
1,096,711 |
0 |
- |
|
| SGEN |
Seagen Inc |
President and CEO |
• • – |
2012-08-20 |
4 |
A |
$0.00 |
$0 |
D/D |
74,250 |
1,170,961 |
0 |
- |
|
| SGEN |
Seagen Inc |
President and CEO |
• • – |
2013-08-19 |
4 |
A |
$0.00 |
$0 |
D/D |
55,000 |
1,124,558 |
0 |
- |
|
| SGEN |
Seagen Inc |
President and CEO |
• • – |
2014-01-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
1,038,554 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Director |
– • – |
2014-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
24,444 |
24,444 |
0 |
- |
|
| SGEN |
Seagen Inc |
President and CEO |
• • – |
2014-05-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
325,479 |
525,217 |
0 |
- |
|
| SGEN |
Seagen Inc |
President and CEO |
• • – |
2014-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
559,710 |
0 |
- |
|
| SGEN |
Seagen Inc |
President and CEO |
• • – |
2014-11-25 |
5 |
GD |
$0.00 |
$0 |
D/D |
2,688 |
557,022 |
0 |
- |
|
| SGEN |
Seagen Inc |
President and CEO |
• • – |
2015-08-25 |
4 |
A |
$0.00 |
$0 |
D/D |
64,000 |
611,323 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
|
– • – |
2016-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,875 |
1,875 |
0 |
- |
|
| SGEN |
Seagen Inc |
President and CEO |
• • – |
2016-08-27 |
4 |
A |
$0.00 |
$0 |
D/D |
72,000 |
604,734 |
0 |
- |
|
| SGEN |
Seagen Inc |
President and CEO |
• • – |
2016-09-10 |
4 |
GD |
$0.00 |
$0 |
I/I |
6,148 |
0 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2017-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
1,875 |
3,750 |
0 |
- |
|
| SGEN |
Seagen Inc |
President and CEO |
• • – |
2017-08-17 |
4 |
A |
$0.00 |
$0 |
D/D |
67,200 |
703,635 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2018-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
6,750 |
0 |
- |
|
| SGEN |
Seagen Inc |
President and CEO |
• • – |
2018-08-30 |
4 |
A |
$0.00 |
$0 |
D/D |
95,981 |
732,613 |
0 |
- |
|
| SGEN |
Seagen Inc |
President and CEO |
• • – |
2019-06-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,875 |
746,294 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2019-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
9,750 |
0 |
- |
|
| SGEN |
Seagen Inc |
See Remarks |
• • – |
2019-08-30 |
4 |
A |
$0.00 |
$0 |
D/D |
48,034 |
765,377 |
0 |
- |
|
| SGEN |
Seagen Inc |
President and CEO |
• • – |
2019-12-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,100 |
758,784 |
0 |
- |
|
376 Records found
|
|
Page 1 of 16 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
